Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Saving America's Pollinators Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Saving America's Pollinators Act of 2015
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · first_quarter · 1A
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Source: Senate LDA
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Saving America's Pollinators Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Advancing Hope Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Advancing Hope Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Advancing Hope Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Safe and Accurate Food Labeling Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Safe and Accurate Food Labeling Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Safe and Accurate Food Labeling Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Protect Medical Innovation Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Protect Medical Innovation Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Protect Medical Innovation Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Medicare Access and CHIP Reauthorization Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Delivering Antimicrobial Transparency in Animals Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Delivering Antimicrobial Transparency in Animals Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Delivering Antimicrobial Transparency in Animals Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Defend Trade Secrets Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Defend Trade Secrets Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Defend Trade Secrets Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Small Agriculture Producer Size Standards Improvements Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Small Agriculture Producer Size Standards Improvements Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Small Agriculture Producer Size Standards Improvements Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
E-Free Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
E-Free Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
E-Free Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
21st Century Cures Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
21st Century Cures Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
21st Century Cures Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Protecting Access to Diabetes Supplies Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Protecting Access to Diabetes Supplies Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Protecting Access to Diabetes Supplies Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Zika Vector Control Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Zika Vector Control Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Zika Vector Control Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Genetically Engineered Food Right-to-Know Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Genetically Engineered Food Right-to-Know Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Genetically Engineered Food Right-to-Know Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Medicare DMEPOS Competitive Bidding Improvement Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medicare DMEPOS Competitive Bidding Improvement Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medicare DMEPOS Competitive Bidding Improvement Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medical Device Access and Innovation Protection Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Medical Device Access and Innovation Protection Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Medical Device Access and Innovation Protection Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Advancing Hope Act of 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Advancing Hope Act of 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Advancing Hope Act of 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Defend Trade Secrets Act of 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Defend Trade Secrets Act of 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Defend Trade Secrets Act of 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Offshore Production and Energizing National Security Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Offshore Production and Energizing National Security Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Offshore Production and Energizing National Security Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Adding Zika Virus to the FDA Priority Review Voucher Program Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Adding Zika Virus to the FDA Priority Review Voucher Program Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Adding Zika Virus to the FDA Priority Review Voucher Program Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Veterinary Medicine Loan Repayment Program Enhancement Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Genetically Engineered Food Right-to-Know Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Genetically Engineered Food Right-to-Know Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Genetically Engineered Food Right-to-Know Act
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Preventing Antibiotic Resistance Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Preventing Antibiotic Resistance Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Preventing Antibiotic Resistance Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Restoring Access to Medication and Improving Health Savings Act of 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Saving America's Pollinators Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Saving America's Pollinators Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Saving America's Pollinators Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Saving America's Pollinators Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Saving America's Pollinators Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Saving America's Pollinators Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Advancing Hope Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Advancing Hope Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Advancing Hope Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Advancing Hope Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Advancing Hope Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015.
Advancing Hope Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Safe and Accurate Food Labeling Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Safe and Accurate Food Labeling Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Safe and Accurate Food Labeling Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Safe and Accurate Food Labeling Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Safe and Accurate Food Labeling Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Safe and Accurate Food Labeling Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Protect Medical Innovation Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Protect Medical Innovation Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act.
Protect Medical Innovation Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act.
Protect Medical Innovation Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 2029, Consolidated Appropriations Act, 2016. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Protect Medical Innovation Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Protect Medical Innovation Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Consolidated Appropriations Act, 2016
Client: BAYER CORPORATION (CONSOLIDATED REPORT) · Firm: BAYER CORPORATION (CONSOLIDATED REPORT)
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 2029, Consolidated Appropriations Act, 2016. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · first_quarter · 1A
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2016 · first_quarter · Q1
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. S. 2609, An original bill to amend the Agricultural Marketing Act of 1946 to require the Secretary of Agriculture to establish a national voluntary labeling standard for bioengineered foods, and for other purposes. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. S. 1878, Advancing Hope Act of 2015. S. 1890, Defend Trade Secrets Act of 2016. S. 2512, Adding Zika Virus to the FDA Priority Review Voucher Program Act. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015. H.R. 3326, Defend Trade Secrets Act of 2016. H.R. 3920, E-Free Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · fourth_quarter · Q4
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015. H.R. 3714, Small Agriculture Producer Size Standards Improvements Act of 2015.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 2029, Consolidated Appropriations Act, 2016. S. 149, Medical Device Access and Innovation Protection Act. S. 440, Veterinary Medicine Loan Repayment Program Enhancement Act.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · third_quarter · 3A
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · third_quarter · Q3
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. S. 149, Medical Device Access and Innovation Protection Act.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · second_quarter · 2A
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · second_quarter · Q2
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2015 · first_quarter · Q1
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · fourth_quarter · Q4
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · third_quarter · Q3
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. Monitor legislative and administrative action related to point-of-care instruments. Monitor legislative and administrative action related to streamlined pathways to market for breakthrough technologies. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · second_quarter · 2A
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013 (P.L. 113-79). H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues. H.R. 2692, Saving America's Pollinators Act of 2013.
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · first_quarter · 1A
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of transparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. oMonitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · second_quarter · Q2
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative issues and administrative action related to Trade and Miscellaneous Trade. Monitor Trade Promotion Authority. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013 (P.L. 113-79). H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues. H.R. 2692, Saving America's Pollinators Act of 2013.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2014 · first_quarter · Q1
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment.Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2013 · fourth_quarter · Q4
S 553/HR 1125, Veterinary Medicine Loan Repayment Program Enhancement Act.
Monitor the implementation of the FY2013 Continuing Appropriations Act, P.L. 113-6.
H.R. 1150, Title: To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases. Title II, General provisions in the bill. S. 1256, Preventing Antibiotic Resistance Act of 2013. A bill to amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases.S.959/HR 3204, Pharmaceutical Compounding Quality and Accountability Act. General provisions of the bill. HR 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2013 · third_quarter · Q3
FY 2013 Homeland Security Appropriations Bill. Support for National Biodefense and Agriculture Facility funding.
S 553 and HR 1125 Veterinary Loan Repayment Program In support for legislation
H.R. 1150 Title: The Federal Food, Drug, Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. title II. General provisions in the billS. 1256 Prevention Antibiotic Resistance Act 2013. A bill to amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases S. 959 Pharmaceutical Compounding Quality and Accountability Act. General provisions of the bill
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2013 · second_quarter · Q2
H.R. 1150 Title: The Federal Food, Drug, Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. title II. General provisions in the bill HR 1407 Title: Animal Drug User Fee Amendments of 2013. HR 1408 Title: Animal Generic Drug User Fee Amendments of 2013.S.622 : Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013. HCR S. 959 Pharmaceutical Compounding Quality and Accountability Act. General provisions of the bill. HCR FDASIA (S 3187, 112th Congress), as it regards to implementation Medical device tax, as it regards to implementation
FY 2013 Homeland Security Appropriations Bill. Support for National Biodefense and Agriculture Facility funding. FY2014 Appropriations FDA and HHS HR 933, the Consolidated and Further Continuing Appropriations Act
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2013 · first_quarter · Q1
FY 2013 Homeland Security Appropriations Bill. Support for National Biodefense and Agriculture Facility funding. FDASIA (S 3187, 112th Congress) as it regards to implementation of FDA funding HR 933 the Consolidated and Further Continuing Appropriations Act
H.R. 1150 The Federal Food, Drug, Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. title II. General provisions in the billS.10 Agriculture Reform, Food, and Jobs Act of 2013 Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species and Pollinators H.R.935 Reducing Regulatory Burdens Act of 2013 Provisions related to National Pollutant Elimination System (NPDES) permits S.175 A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides. Provisions related to National Pollutant Elimination System (NPDES) permits H.R.933 Consolidated and Further Continuing Appropriations Act, 2013 Provisions related to pesticide fees (PRIA) and agriculture appropriations H.R.8 American Taxpayer Relief Act of 2012 Provisions related to extension of the Farm Bill. Bee Health Discussions on EPA regulatory actions involving pollinator protection and bee health Biotech Labeling Discussions related to biotech labeling of food. Farm Bill Discussions related to pesticide registrations under the Endangered Species Act.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2012 · fourth_quarter · Q4
H. R. 525 Veterinary Public Health Amendments Act. An act to amend the Public Health Service Act to enhance and increase the number of veterinarians trained in veterinary public health. Lobbied House and Senate S 518 Veterinary Loan Repayment Program In support for legislation.
HR 5973 FY 2013 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act. General provisions of the bill related to animal drugs and biologics.
H.R. 872 and S 3605 Reducing Regulatory Burdens Act of 2011. Provisions related to NPDES permits s. 3240 Agriculture Reform, Food, and Job ACt of 2012. Provisions related to NPDES permits Farm Bill: Discussion of Farm Bill Extensions. Provisions related to NPDES, ESA, and Pollinators Discussion of EPA regulatory actions involving pollinators protection and bee health. S 1053 Veterinary Services Investment Act. General support of the bill. H.R. 965 The Federal Food, Drug, Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. title II. General provisions in the bill S 1211 Companion to above (HR 965)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2012 · third_quarter · Q3
S3552: Discussions on EPA regarding reauthorization of the Pesticide Registration Improvement Act H.R.872 and S. 3605: Reducing Regulatory Burdens Act of 2011. Provisions related to NPDES permits. S. 3240: Agriculture Reform, Food, and Jobs Act of 2012. Provisions related to NPDES permits. H.R. 965 Title: The Federal Food, Drug, Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases. title II. General provisions in the bill. S 1211 Companion bill to to HR 965 S 1053 Title: Veterinary Services Investment Act. General support of the bill. Farm bill - Discussion draft of House Farm bill. Provisions related to NPDES, PRIA, Pollinators. ESA - Discussions on biological opinions and impact on agriculture, and need for streamlined consultation process with National Marine Fisheries, and Fish and Wildlife Service. Spray Drift - Discussions on proposed EPA guidance for pesticide label language on preventing spray drift.
H. R. 525 Veterinary Public Health Amendments Act. An act to amend the Public Health Service Act to enhance and increase the number of veterinarians trained in veterinary public health. S 518 Veterinary Loan Repayment Program In support for legislation.
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2012 · second_quarter · Q2
HR 5973 FY 2013 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act; (General provisions of the bill related to animal drugs and biologics.) HR 5855 Department of Homeland Security Appropriations Act, 2013; (Support for National Biodefense and Agriculture Facility funding.)
HR 432/ S136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4223 The "Safe Doses Act"; (All provisions of the bill.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All parts.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All parts.) Draft Discussion of FDA User Fees; (All parts) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Provisions relating drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 436 Health Care Cost Reduction Act of 2012; (Provisions related to medical device taxes.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2012 · first_quarter · Q1
HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) "Meth Lab Elimination Act of 2010" a draft by Senator Wyden; (All parts relating to pseudoephedrine.) "Maintaining Consumer Access to Cough Medicine Act of 2011", a draft; (All part relating to DXM.) HR 1406 Fairness to Pet Owners Act 2011; (General provisions requiring Veterinary prescribing.) HR 525 Veterinary Public Health Amendments Act: An act to amend the Public Health Service Act to enhance and increase the number of veterinarians trained in veterinary public health; (General provisions of the bill.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2011 · fourth_quarter · Q4
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act; (Provisions related to MDUFMA.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2011 · third_quarter · Q3
HR 525 Veterinary Public Health Amendments Act: an act to amend the Public Health Service Act to enhance and increase the number of veterinarians trained in veterinary public health; (General provisions of the bill.) HR 1406 Fairness to Pet Owners Act 2011; (General provisions requiring veterinary prescribing.) HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9) S 518 Veterinary Loan Repayment Program; (In support for legislation.)
S 518 Veterinary Loan Repayment Program; (In support of legislation.)
HR 525 Veterinary Public Health Amendments Act: An act to amend the Public health service Act to enhance and increase the number of veterinarians trained in veterinary public health; (General provisions of the bill.) HR 1406 fairness to Pet Owners Act of 2011; (General provisions requiring veterinary prescribing.) Combat Meth epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 the Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy &commerce hearings on 9/23/11.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2011 · second_quarter · Q2
S 518 Veterinary Loan Repayment Program; (In support of legislation.) HR 1406 Fairness to Pet Owners Act 2011; (General provisions requiring veterinary prescribing.) HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9)
HR 908 Full Implementation of the "Chemical Facilities Anti-Terrorism Act" (CFATS); (All provisions of the bill related to the reauthorization of CFATS through 2017.) HR 901 Full Implementation of the "Chemical Facility Anti-Terrorism Security (CFATS) Authorization Act of 2011"'; (All provisions related to implementation of the CFATS program.) S 473 Continuing Chemical Facilities Anti-Terrorism Security Act of 2011: A bill to extend the Chemical Facilities Anti-Terrorism Standards (CFATS) until October 14, 2014; (All provisions related to implementation of CFATS.) S 709 Secure Chemical Facilities Act: A bill to insure adequate security is employed at chemical plants; (All provisions related to chemical risk management, tiered assessments, audits, standard setting and inspections.) HR 2017 FY 2012 Homeland Security Appropriations Bill; (Support funding for National Bio and Agriculture Facility.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2011 · first_quarter · Q1
S 518 Veterinary Loan Repayment Program; (In support for legislation.)
HR 432/S 136 Ban Poisonous Addiditives Act of 2011, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 965 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (title II. General provision in the bill.) S 17/S 262/ HR 436/HR 488/HR 734 Medical Device Access and Innovation Protection Act; (Provisions related to the medical device tax repeal.) S 18/S 72/HR 4/HR 60/HR 144/HR 584/HR 705 Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 16/S 193/HR 141/HR 145/HR 429/HR 636 Patient Choice Restoration Act; (Provisions related to healthcare reform repeal.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · fourth_quarter · Q4
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.) H Res 1531/S Res 583 Expressing Support for Designation of 2011 as "World Veterinarian Year"; (Support resolution.)
HR 2868/S 2996 To amend the Homeland Security Act of 2002 to extend, modify, and recodify the authority of the Secretary of Homeland Security to enhance security and protect against acts of terrorism against chemical facilities, and for other purposes; (Provisions related to issues that could affect farmers and those relating to extending CFATS regulations, IST provisions and citizen enforcement provisions.) S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions related to agriculture activites and the section changing the definition of U.S. Waters.) HR 5504/S 3307 Healthy, Hunger-Free Kids Act of 2010; (Provisions related to organic food.) S 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011; (All provisions related to APHIS and BRS funding.) HR 6273 To amend the Federal Insecticide, Fungicide, and Rodenticide Act to exempt the application of pesticides subject to that Act, when applied in conformance with that Act, from certain permit requirements under the Federal Water Pollution Control Act, and for other purposes; (Provisions related to NPDES permits for agriculture.) S 3735 A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides; (Provisions related to NPDES permits for agriculture.) HR 6087 To amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides; (Provisons related to NPDES permits for agriculture.) EPA/Environment Appropriations (no bill number): Seeking funding for the FY2011 appropriations; (All provisions related to agriculture, EPA and pesticide fees.) Regulatory Biotech Issues (No bill numbers); (Provisions in proposed regulations regarding the approval of biotect traits and all other issues related to biotect regulations, including APHIS part 340 regs.) ESA Issues (No bill number) NMFS Biological opinions; (Discussions on National Marine Fisheries Biological Opinions that were recently released and their potential affects on agriculture.) EPA Regulations (No bill number): Guidance on spray drift; (Provisions in the guidance related to "may cause harm" and changes to FIFRA.) PRIA -- pesticide fees; (Provisions regarding reauthorization.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · third_quarter · Q3
HR 2999Veterinary Public Health Workforce and Education Act; (In support for legislation.) HR 3519/S1709 Veterinary Services Investment Act; (Support legislation.) H Res 1531/S Res 583 Expressing Support for Designation of 2011 as "World Veterinarian Year"; (Support legislation.)
HR 1549/S 619 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 2749 Food Safety Enhancement Act 2009: To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title I Food Safety. Monitoring food safety provisions. All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) S 510 FDA Food Safety Modernization Act: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply; (Monitoring provisions of the bill.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.) HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.) HR 4213 "American Jobs and Closing Tax Loopholes Act of 2010"; (Sections pertaining to AMP, and allocations systems.) S.AMDT 4369 to HR 4213 In the nature of a substitute; (Sections pertaining to AMP, and allocations systems.) HR 6228/S 593 The Ban Poinsonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphneol-A containing products.) S 753 the Children's Safe Chemical Act: A ban on food contact materials for children and infants (3years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food, Drug and cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphnol-A in food applications.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs; All provisions relating to healthcare.) HR 4872 The Healthcare and Education Reconciliation Act of 2010; (Provisions relating to healthcare.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · first_quarter · 1A
HR 6228/S 593 the Ban Poisonous act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the lable of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal disease; (Title II. General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other puposes; (Title I food Safety,; Monitoring food safety provisions.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.) HR 3519/S 1709 Veterninary Services Investment Act; (Support of legislation.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (all relating to follow-on biologics.) S 1142 The "Informed Health Care Decision Making" Act of 2009; (Sections pertaining to comparative effectiveness.) HR 1321 Healthy Americans Act; (Relating to Medicare) Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009 (All provisions.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provsions relating to healthcare; all provisions related to competitive acquisition for durable medical equipment and prosthetics, orthotics, and supplies.).) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; provisions related to subtitles A, B, C, and D.) HR 4872 The Health Care and Education Afforability Reconciliation Act; (All provisions dealing with phramaceuticals and medical devices.) S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) S 1679 Affordable Health Choices Act; (Provsions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3790 To Amend Title XVIII of the Social Security Act to repeal the Medicare competitive aquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); (All provisions related to competitive acquistionf for durable medical equipment and prosthetics, orthotcs, and supplies.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · second_quarter · Q2
HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.) HR 2999 Veterinary Public Health Workforce and Education; (In supoprt for legislation.)
FY 2011 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act; (General provisions of the bill related to animal drugs and biologics.)
HR 2868/S 2996 To amend the Homeland Security Act of 2002 to extend, modify, and recodify the authority of the Secretary of Homeland Security to enhance security and protect against acts of terrorism against chemical facilities, and for other purposes; (Provisions related to issues that could affect farmers and those relating to extending CFATS regulations, IST provisions and citizen enforcement provisions.) S 787 A bill to amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions related to agriculture activities and the section changing the definition of U.S. Waters.) HR 2454 To create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions related to agriculture activities, allowances/offsets and credits and the "cap and trade" system for agriculture.) S 1733 A bill to create clean energy jobs, promote energy independence, reduce global warming pollution, and transition to a clean energy economy; (All provisions related to agriculture, allowances and offsets.) HR 4159 A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to require local educational agencies and schools to implement integrated pest management programs to minimize the use of pesticides in schools and to provide parents, guardians, and employees with notice of the use of pesticides in schools, and for other purposes; (Provisions relating to pesticides.) S 3535 A bill to enhance the energy security of the United States; (All provisions related to agriculture.) S 3464 A bill to establish an energy and climate framework; (All provisions related to agriculture.) Appropriations: Seeking funding for the FY 2011 appropriations; (All provisions related to agriculture, EPA and pesticide fees.) NPDES permitting issues; (Permitting issues concerning agriculture applications.) PRIA: pesticide fees; (Reauthorization.) Regulatory Biotech Issues; (Provisions in proposed regulations regarding the approval of biotech traits and all other issues related to biotech regulations, including APHIS part 340 regs.) ESA Issues: NMFS Biological opinions; (Discussions on National Marine Fisheries Biological Opinions that we recently released and their potential affects on agriculture.) ESA Spray Drift: Guidance on spray drift; (Provisions in the guidance related to "may cause harm" and changes to FIFRA.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2010 · first_quarter · Q1
HR 2999 Veterinary Public Health Workforce and Education Act;(In support for legislation.) HR 3519/S1709 Veterinary Services Investment Act; (Support legislation.)
HR 6228/S 593 the Ban Poisonous act of 2009, a bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act, a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009, a bill to amend the Food, Drug, and Cosmetic Act to require a warning on the lable of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal disease; (Title II. General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other puposes; (Title I food Safety,; Monitoring food safety provisions.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.) HR 3519/S 1709 Veterninary Services Investment Act; (Support of legislation.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (all relating to follow-on biologics.) S 1142 The "Informed Health Care Decision Making" Act of 2009; (Sections pertaining to comparative effectiveness.) HR 1321 Healthy Americans Act; (Relating to Medicare) Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009 (All provisions.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provsions relating to healthcare.) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; provisions related to subtitles A, B, C, and D.) HR 4872 The Health Care and Education Afforability Reconciliation Act; (All provisions dealing with phramaceuticals and medical devices.) S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) S 1679 Affordable Health Choices Act; (Provsions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2009 · fourth_quarter · Q4
HR 4159 A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to require local educational agencies and schools to implement integrated pest management programs to minimize the use of pesticides in schools and to provide parents, guardians, and employees with notice of the use of pesticides in schools, and for other purposes; (Provisions relating to pesticides.) S. 787 A bill to amend the Federal Water Pollution Control Act to clarity the jurisdition of the United States over waters of the United States; (Provisions related to agriculture activities and the section changing the definition of U.S. Waters.) HR 2454 To create clean energy jobs, achieve energy independence, reduce global warming pollution and transition to a clean energy economy; (All provisions related to agriculture activities, allowances/offsets and credits and the "cap and trade" system for agriculture.) S 1733 A bill to create clean energy jobs, promote energy jobs, promote energy independence, reduce global warming pollution, and transition to a clean energy economy; (All provisions related to agriculture, allowances and offsets.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2009 · third_quarter · Q3
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.)
H Res 317/S Res 174 Recognizing Kansas and Missouri as the animal health corridor in the US; (Support for resolution.) HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.) HR 3519/S 1709 Veterinary Services Investment Act; (Support for legislation.)
ESA Issues; (NMFS Biological opinions -- Discussions on a National Marine Fisheries Biological Opinions that were recently released and their potential affects on agriculture.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2009 · second_quarter · Q2
H Res 317/S Res 174 Recognizing Kansas and Missouri as the animal health corridor in the US; (Provisions relating to support.) To Establish Veterinary Services Investment Act; (In support for legislation.)
H. Res 317/S. Res 174 Recognizing Kansas and Missouri as the animal health corridor in the US; (Support for the bill.)
To Establish Veterinary Services Investment Act; (In support for legislation.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2008 · fourth_quarter · Q4
H.R. 1232/S. 746 to establish a competitive grant program to build capacity in veterinary medical education and expand the workforce of veterinarians engaged in public health practice and biomedical research; (Section 2. Competitive Grants Program.)
S. 3289 An original bill making appropriations for the Agriculture, Rural Development, Food and Drug Aministration, and Related Agencies programs for the fiscal year ending September 30, 2009, and for other purposes; (Provisions relating to NASS funding.)
H.R. 1148 Safe Food Act 2007; (Title II, Monitoring provisions relating to administration of Food Safety Programs.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2008 · third_quarter · Q3
H.R. 1232/S. 746 to establish a competitive grant program to build capacity in veterinary medical education and expand the workforce of veterinarians engaged in public health practice and biomedical research; (Section 2. Competitive Grants Program.)
H.R. 1148 Safe Food Act 2007; (Title II, Monitoring provisions relating to administration of Food Safety Programs.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2008 · second_quarter · Q2
H.R. 1148 Safe food Act 2007; (Title II, Monitoring provisions relating to administration of Food Safety Programs.)
H.R. 1232/S. 746 to establish a competitive grant program to build capacity in veterinary medical education and expand the workforce of veterinarians engaged in public health practice and biomedical research; (Section 2. Competitive Grants Program.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2008 · first_quarter · Q1
H.R. 1148 Safe Food Act 2007; (Title II, Monitoring provisions relating to administration of food Safety Programs.)
H.R. 1232/S. 746 To establish a competitive grant program to build capacity in veterinary medical education and expand the workforce of veterinarians engaged in public health practice and biomedical research; (Section 2. Competitive Grants Program.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2007 · year_end · YY
Protocol Number 901-20, USA-Germany Tax Treaty; (Provisions relating to human resources; employee transparency; business fairness; updating and improving US foreign investment realtions and statutory requirements.) Protocol Number 901-25, USA-Belgium Tax Treaty; (All provisions relating to human resources; employee transparency; business fairness; updating and improving US Foreigh investment relations and statutory requirements.)
* H.R. 2419/S. 2302 To provide for the continuation of agricultural programs through fiscal year 2012, and for other purposes; (Provisions relating to farm commodity programs, conservation, pollinators and bio-fuels.) H.R. 4193 To provide for an automatic one-year extension of the authorizations of appropriations and direct spending programs of the Farm Security and Rural Investment Act of 2002, and for other puproses; (Provisions related to farm subsidies.) H.R. 2401 To provide for greater access and opportunites for socially disadvantaged farmers, to create incentives for research, conservation, and market viability, to provide a healthy and just work environment for agricultural workers, to provide Americans with healthier food choices, to address hunger and poverty in the United States, and for other purposes; (Sections 401, 503. 505-507, 607, 701; (Provisions relating to farm conservation programs.) H.R. 2419 Farm Bill Extension Act 2007; Provisions related to title II Conservation Programs; (Title IV Nutrition Progams.) H. Res. 829 Recognizing the KC Animal Health Corridor from....Kansas to Missouri; (Support for this resolution.) H.R. 2401 To provide for greater access and opportunites for socially disadvantaged farmers, to create incentives for research, conservation, and market viability, to provide a healthy and just work environment for agricultural workers, to provide Americans with healthier food choices, to address hunger and poverty in the United States, and for other purposes; (Sections 401, 503. 505-507, 607, 701; (Provisions relating to farm conservation programs.) H.R. 2419 Farm Bill Extension Act 2007; Provisions related to title II Conservation Programs; (Title IV Nutrition Progams.) H. Res. 829 Recognizing the KC Animal Health Corridor from....Kansas to Missouri; (Support for this resolution.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2007 · mid_year · MA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2007 · mid_year · MM
Protocol number 901-20, USA-Germany Tax Treaty; (Provisions relating to human resources; employee transparency; business fairness; updating and improving US Foreign investment relations and statutory requirements.) Protocol Number 901-25, USA-Belgium Tax Treaty; (All provisions relating to human resources; employee transparency; business fairness; updating and improving US Foreign investment relations and statutory requirements.)
H.R. 1165, Swift Approval, Full Evaluation Drug Act of the "SAFE Drug Act"; (Provisions relating to drug safety.) H.R. 970, Gang Prevention and Effective Deterrence Act of 2005; (Provisions relating to bulk distribution of DXM) H.R. 780, The "Counterfeit Drug Prevention Act of 2007"; (Provisions relating to prevention of counterfeit drugs.)
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2006 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION (CONSOLIDATED REPORT) via BAYER CORPORATION (CONSOLIDATED REPORT)
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to womens health issues. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor legislative and administrative action related to over-the-counter consumer care products. Monitor legislative and administrative action related to age restrictions on access to particular drugs. Monitor activities related to the implementation of the Drug Quality and Security Act (2013). Monitor legislative and administrative action related to dietary supplements. H.R. 6, 21st Century Cures Act. H.R. 771, Protecting Access to Diabetes Supplies Act of 2015. H.R. 1537, Advancing Hope Act of 2015. H.R. 2459, Delivering Antimicrobial Transparency in Animals Act of 2015.
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 897, Reducing Regulatory Burdens Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Monitor legislative and federal activity related to tax reform. H.R. 160, Protect Medical Innovation Act of 2015. H.R. 1270, Restoring Access to Medication Act of 2015. S. 149, Medical Device Access and Innovation Protection Act. S. 709, Restoring Access to Medication Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to pollinator health and habitat promotion. Monitor legislative and administrative action related to pesticide registration. Monitor legislative and administrative action related to biotechnology deregulation. Monitor legislative and administrative action related to genetically modified labeling. S. 511, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 621, Preventing Antibiotic Resistance Act of 2015. H.R. 913, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R. 1284, Saving Americas Pollinators Act of 2015. H.R. 1599, Safe and Accurate Food Labeling Act of 2015.
Monitor legislative and administrative action related to Medicare policy. Monitor legislative and administrative action related to sustainable growth rate, SGR fix, and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. S. 148, Medicare DMEPOS Competitive Bidding Improvement Act of 2015. H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Agriculture, Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative issues and administrative action related to Trade and Miscellaneous Trade. Monitor Trade Promotion Authority. Monitor legislative and administrative action related to export classification. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. Monitor legislative and administrative action related to point-of-care instruments. Monitor legislative and administrative action related to streamlined pathways to market for breakthrough technologies. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act. S. 2917, Adding Ebola to the FDA Priority Review Voucher Program Act. H.R. 3969, Preventing Abuse of Cough Treatments Act of 2014 or the PACT Act. S. 644, Preventing Abuse of Cough Treatments Act of 2013 or the PACT Act.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues. H.R. 2692, Saving America's Pollinators Act of 2013. H.R. 5447, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to increase the availability of pesticides for the management of parasitic pests that adversely impact the health of managed pollinator bees, and for other purposes.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Monitor enforcement of Medicares imaging equipment preventative maintenance policy. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to Medicare payment for diabetes testing strips, drug rebates for Medicare Part D, and the Independent Payment Advisory Board (IPAB). Monitor legislative and administrative action related to CMS Competitive Bidding. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213.
Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency. Draft, Senate tax extender legislation. H.R. 523, Protect Medical Innovation Act of 2013. H.R. 2835, Restoring Access to Medication Act of 2013. S. 1647, Restoring Access to Medication Act. S.232, Medical Device Access and Innovation Protection Act.
Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative issues and administrative action related to Trade and Miscellaneous Trade. Monitor Trade Promotion Authority. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues. H.R. 2692, Saving America's Pollinators Act of 2013. H.R. 5447, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to increase the availability of pesticides for the management of parasitic pests that adversely impact the health of managed pollinator bees, and for other purposes.
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. Monitor legislative issues and administrative action related to Trade and Miscellaneous Trade. Monitor Trade Promotion Authority. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014. H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013 (P.L. 113-79). H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues.
H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Monitor legislative and administrative action related to pollinator health and habitat promotion. S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013 (P.L. 113-79).H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators. S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. S. 1256, Preventing Antibiotic Resistance Act of 2013. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues.
Monitor legislative and administrative action on appropriations and budget. Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015.Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015. Draft, Senate Interior and Environment Appropriations Act, 2015. Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015. Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015. Draft, House National Defense Authorization Act, 2015. Draft, Senate National Defense Authorization Act, 2015. Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
Monitor legislative and administrative action related to trade promotion authority negotiations. Monitor legislative and administrative action related to Trans-Pacific Partnerships. Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership. S. 1900, Bipartisan Congressional Trade Priorities Act of 2014.H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 553 and HR 1125 Veterinary Loan Repayment Program In support for legislation.
S. 954 Agriculture Reform, Food, and Jobs Act of 2013 Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators.H.R. 1947 Federal Agriculture Reform and Risk Management Act of 2013 Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Biotechnology, Winter Wheat Cereals Project and Pollinators. S. 809 Genetically Engineered Food Right-to-Know Act Provisions related to labeling. Discussions on EPA regulatory actions involving pollinator protection and bee health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 553 and HR 1125 Veterinary Loan Repayment Program In support for legislation. HR 1407 Animal Drug User Fee Amendments of 2013 HR 1408 Animal Generic Drug User Fee Amendments of 2013 S.622 : Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 709 Secure Chemical Facilities Act-a bill to insure adequate security is employed at chemical plants. All provisions related to chemical risk management, tiered assessments, audits, standard setting and inspections. HR 908: Full Implementation of the Chemical Facilities Anti-Terrorism Act(CFATS) All provisions of the bill related to the reauthorization of CFATS through 2017 HR 5855 FY 2013 Homeland Security Appropriations Bill. Support for National Biodefense and Agriculture Facility funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 5973 FY 2013 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act. General provisions of the bill related to animal drugs and biologics. HR 5855 FY 2013 Homeland Security Appropriations Bill. Support for National Biodefense and Agriculture Facility funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 518 Veterinary Loan Repayment Program; (In support of legislation.)
S 3187 Food and Drug Administration Safety and Innovation Act; (Provisions related to medical devices.) Safe Injection Practices (no bill number); (Provisions related to safer injection practices.) HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9.)
HR 525 Veterinary Public Health Amendments Act: An act to amend the Public Health Service Act to enhance and increase the number of veterinarians trained in veterinary public health; (General provisions in the bill.) S 518 Veterinary Loan Repayment Program; (In support of legislation.) HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9.) HR 1406 Fairness to Pet Owners Act 2011; (General provision requiring veterinary prescribing.)
HR 4223 The "Safe Doses Act"; (All parts.) HR 3668 The "Counterfeit Drug Penalty Enhancement Act of 2011"; (All provisions.) HR 4216 The "Foreign Counterfeit Prevention Act"; (All provisions.) Draft Discussion on FDA User Fees; (All provisions.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic report and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.) Meth Lab Elimination Act of 2010, a draft by Senator Wyden; (All parts relating to pseudoephedrine.) Maintaining Consumer Access to Cough Medicine Act of 2011, a draft; (All parts relating to DXM.) HR 525 Veterinary Public Health Amendments Act: An act to amend the Public Health Service Act to enhance and increase the number of veterinarians trained in veterinary public health.) HR 1406 Fairness to Pet Owners Act 2011; (General provisions requiring veterinary prescribing.)
HR 872 Reducing Regulatory Burdens Act of 2011; (Provisions related to NPDES permits.) S 3240 Agriculture Reform, Food and Jobs Act of 2012; (Provisions related to NPDES permits; provisions relating to pesticides, biotechnology, agriculture research and conservation.) S 2375 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013; (All provisions related to funding of USDA agencies including APHIS and FAS.) Regulatory Biotech Issues (no bill numbers); (Provisions in proposed regulations regarding the approval of biotech traits and all other issues related to biotech regulations.) ESA (no bill); (NMFS Biological opinions -- Discussions on National Marine Fisheries Biological Opinions and their potential affects on agriculture and the need for a resolution to the consultation process.) Spray Drift (no bill number);Discussions on proposed EPA guidance for pesticide label language on preventing spray drift.) PRIA (no bill number); (Discussions on EPA regarding reauthorization of the Pesticide Registration Improvement Act (PRIA).) Farm Bill (no bill number); Discussion draft of House Farm bill; (Provisions related to NPDES, PRIA, Pollinators.) Bee Health (no bill number); (Discussions on EPA regulatory actions involving pollinator protection and bee health.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9.)
HR 965/S 1211 The Federal Food, Drug and Cosmetic Act to preserve the effectiveness of medially important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions of the bill.) HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 3209 HR 3204/S 1700/PL 107-250 Medical Device User Fee and Modernization Act (MDUFMA); (Provisions related to MDUFMA.) HR 4223 The Safe Doses Act; (All provisions of the bill.) HR 3668 The Counterfeit Drug Penalty Enhancement Act of 2011; (All provisions of the bill.) HR 4216 The Foreign Counterfeit Prevention Act; (All provisions of the bill.) Draft Discussion on FDA User Fees; (All parts.) S 365 Balanced Budget Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11.)
S 518 Veterinary Loan Repayment Program; (In support for legislation.) HR 1406 Fairness to Pet Owners Act 2011; (General provisions requiring veterinary prescribing.) HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9.) HR 525 Veterinary Public Health Amendments Act: An act to amend the Public Health Service Act to enhance and increase the number of veterinarians trained in veterinary public health; (General provisions of the bill.)
S 518 Veterinary Loan Repayment Program; (In support of legislation.)
FY 2013 Agriculture, Rural Devopment, Food and Drug Administration and Related Agencies Appropriations Act (no bill number); (General provisions of the bill related to animal drugs and biologics.) FY 2013 Homeland Security Appropriations Bill (no bill number); (Support for National Biodefense and Agriculture Facility funding.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 525 Veterinary Public Health Amendments Act: An act to amend the Public Health Service Act to enhance and increase the number of veterinarians trained in veterinary public health; (General provisions of the bill.) S 518 Veterinary Loan Repayment Program; (In support for legislation.) HR 1406 Fairness to Pet Owners Act 2011; (General provisions requiring veterinary prescribing.) HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9.)
S 518 Veterinary Loan Repayment Program; (In support for legislation.)
Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic report and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) "Meth Lab Elimination Act of 2010", a draft by Senator Wyden; (All parts relating to pseudoephedrine.) "Maintaining Consumer Access to Cough Medicine Act of 2011", a draft; (All parts relating to DXM.) HR 525 Veterinary Public Health Amendments Act: An act to amend the Public Health service Act to enhance and increase the number of veterinarians trained in veterinary public health; (General provisions of the bill.) HR 1406 Fairness to Pet Owners Act 2011; (General provisions requiring veterinary prescribing.)
HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines ins Sec. 9.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 436/HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 584/HR 705/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) S 365 Balanced budge Control Act of 2011; (Sections pertaining to healthcare expenditures, Medicare Part D drug benefits.) Combat Meth Epidemic Act of 2005; (Sections pertaining to electronic reporting and stop sale.) HR 2245 The Preserving Access to Life Saving Medications Act of 2011; (Drug shortage issues, those issues related to FDA, PDUFA IV and Energy & Commerce hearings on 9/23/11) Labor, HHS, and Education Appropriations Bill draft; (sections relating to efforts to defund PPACA.) HR141/HR 145/HR 215/HR 429, HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) HR 965/S 1211 The Federal food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases.) HR 432/S 136 ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A.)
HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9)
HR 2112 FY 2012 Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act; (General provisions of the bill related to animal drugs and biologics.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 518 Veterinary Loan Repayment Program; (In support of legislation.)
HR 2112 Agriculture Appropriations for FY 2012; (Provisions related to agriculture and farm bill programs; Programs related to agriculture research and USDA funding and any provisions that could affect biotech regulations.) EPA Appropriations (no bill number); (Seeking funding for FY 2012; (Provisions related to agriculture, EPA, and pesticide fees.)
HR 1406 Fairness to Pet Owners Act 2011; (General provisions requiring veterinary prescribing.) HR 2818 Methamphetamine Education, Treatment, and Hope Act; (Those parts pertaining to development of a national clearinghouse for information.)
HR 1733/S 886 Interstate Horseracing Act 2011; (Definition of performance medicines in Sec. 9)
HR 872 Reducing Regulatory Burdens Act of 2011; (Provisions related to NPDES permits.) ESA Issues; (Discussions on biological opinions and impact on agriculture, need for streamlined consultation process with National Marine Fisheries, and Fish and Wildlife Service, and the need for a resolution to the consultation process.) Bee Health; (Discussions on EPA regulatory actions involving pollinator protection and bee health.) PRIA (no bill numbers); (Discussions on EPA regarding reauthorization of the Pesticide Registration Improvement Act.) HR 1249/S 23 America Invents Act; (Provisions related to false markings and other provisions that could affect agriculture.) HR 2112 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012; (Provisions related to agriculture research and USDA funding and any provisions that could affect biotech regulations.) Regulatory Biotech Issues (no bill numbers); (Provisions in proposed regulations regarding the approval of biotech traits and all other issues related to biotech regulations, including APHIS part 340 regs.) Spray Drift (no bill numbers); (Discussions on proposed EPA guidance for pesticide label language on preventing spray drift.)
HR 432/S 136 Ban Poisonous Additives Act of 2011: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 452 Medicare Decisions Accountability Act of 2011; (Provisions relating to entire bill.) South Korean Free Trade Agreement; (Sections pertaining to offsets, including imaging utilization rates.) HR 436/ HR 488/HR 734/S 17/S 262 Medical Device Tax Repeal; (Provisions related to entire bill.) HR 4/HR 60/HR 144/HR 705/HR 584/S 18/S 72 The Small Business Paperwork Mandate Elimination Act of 2011; (Provisions related to the 1099 repeal.) HR 141/HR 145/HR 215/HR 429/HR 636/S 16/S 193 To repeal the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; (Provisions related to Health Care Reform repeal.) PL 107-250 The Medical Device User Fee and Modernization Act (MDUFMA); (provisions related to MDUFMA.) HR 965/S 1211 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 605 Patients' Freedom to Choose Act; (General provisions in the bill.) Medicare Part D (no bill number); (Provisions related to Medicare Part D)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY 2011 Appropriation Bill, consolidated appropriaions bill for the Department of Homeland Security; (Support funding for the National Bio and Agriculture Defense Facility.) FY 2011 Agriculture, Rural Development, Food and Drug Administraion and Related Agencies Appropriations Act (No bill number assigned); (General provisions of the bill related to animal drugs and biologics.)
S 518 Veterinary Loan Repayment Program; (In support for legislation)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S 3606 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011; (All provisions related to APHIS and BRS funding.) EPA/Environment Appropriations (no bill number) Seeking funding for the FY2011 appropriations; (All provisions related to agriculture, EPA and pesticide fees.)
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.) HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.) H Res 1531/S Res 583 Expressing Support for Designation of 2011 as "World Veterinarian Year"; (Support legislation.)
HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title 1 Food Safety. Monitoring food safety provisions.) S 510 FDA food Safety Modernization Act: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the safety of the food supply; (Monitoring provisions of the bill; All sections.) HR 2400 Strategies to address antimicrobial resistance; (Section 3 (c) relating to authorities over antimicrobial drug data collection.) HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.) HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol-A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009: A reform of the law on food safety protection; (all provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) S 753 the Children's Safe Chemical Act: A ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 1523/S 593 The Ban Poisonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) HR 4994 Medicare and Medicaid Extenders Act of 2010; (Sections pertaining to competitive bidding of DME.) S 3653 Health Care Bureaucrats Elimination Act; (Sections pertaining to the IPAB.) HR 2751 FDA Food Safety Modernization Act; (Sections pertaining to inspections.) HR 3590 Patient Protections and Affordable Care Act; (All provisions relating to healthcare) HR 4872 The Healthcare and Education Reconciliation Act of 2010; (Provisions relating to healthcare.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.) H Res 1531/S Res 583 Expressing Support for Designation of 2011 as "World Veterinarian Year" (Support legislation.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.)
HR 2999 Veterinary Public Health Workforce and Education Act;(In support for legislation.) HR 3519/S1709 Veterinary Services Investment Act; (Support legislation.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2999 Veterinary Public Health Workfoce and Education Act; (In support for legislation.)
HR 1549/S 619 To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II General provisions in the bill.) HR 2749 Food Safety Enhancement Act of 2009 to amend the Federal Food, Drug, and Cosmetic Act to improve the safety of food in the global market, and for other purposes; (Title 1 Food Safety. Monitoring food safety provisions.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over Antimicrobial drug data collection.) HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.) HR 6228/S 593 The Ban Poisonous Additives Act of 2009: A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (All provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act: A ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol-A Consumer Information Act 2009: A bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part of Bisphenol-A or could release Bisphenol-a into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 3962 Affordable Health Care for America Act; (Provisions related to subtitle, A,B,C, and D.) HR 4213 "American Jobs and Closing Tax Loopholes Act of 2010" (Sections pertaining to AMP, and allocation systems; all provisions related to pharmaceuticals and medical devices) S.Amdt 4369 to HR 4213 In the Nature of a substitute; (Sections pertaining to AMP, and allocation systems.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All relating to follow on biologics.) S 1142 the "Informed Health Care Decisions Making Act of 2009; (sections pertaining to comparative effectiveness.) HR 1321 Healthy Americans Act; (Relating to Medicare) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs; All provisions relating to healthcare.) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs; All provisions related to pharmaceuticals and medical devices.) HR 4899 Making Emergency Supplemental Appropriations for Fiscal Year 2010; (All provisions related to pharmaceuticals and medical devices.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 2892/S 1298 Fiscal 2010 Homeland Security Appropriations, making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2010, and for other purposes; (General provisions of the bill.)
HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.)
S. Res 174 Recognizing Kansas and Missouri as the animal health corridor in the U.S. (Support for Resolution.) HR 2999 Veterinary Public Health Workforce and Education Act; (In support for legislation.) HR 3519/S 1709 Veterinary Services Investment Act; (Support legislation.)
HR 6228/S 593 The Ban Poisonous Act of 2009, A bill to ban the use of Bisphenol-A in food containers, and for other purposes; (all provisions pertaining to the ban of food contact applications and the science used to support the ban on Bisphenol-A containing products.) S 753 The Children's Safe Chemical Act a ban on food contact materials for children and infants (3 years and under); (All provisions and amendments pertaining to the ban and the testing are relevant.) HR 4341 Bisphenol -A Consumer Information Act of 2009, a bill to amend the Food Drug and Cosmetic Act to require a warning on the label of any food container that is composed, in whole or in part, of Bisphenol-A or could release Bisphenol A into the food; (All provisions relating to the science, restrictions on use and applications of Bisphenol-A in food applications.) HR 2749 Food Safety Enhancement Act of 2009, a reform of the law on food safety protection; (All provisions pertaining to the FDA mandate to make a safety determination on BPA before the end of the year.) HR 1427 Promoting Innovation and Access to Life-Saving Medicine Act; (All provisions relating to follow on biologics.) S 1142 The "Informed Health Care Decisions Making Act of 2009; (Sections pertaining to comparative effectiveness.) HR 1321 Healty Americans Act; (Provisions relating to Medicare.) Senate Finance Committee Chairman's Mark, America's Healthy Future Act of 2009; (All provisions.) HR 3590 Patient Protection and Affordable Care Act; (Sections relating to health insurance and drugs, all provisions relating to healthcare) HR 3962 Affordable Health Care for America Act; (Sections relating to health insurance and drugs, provisions related to subtitles A,B, C and D.) Senate: Patient Protection & Affordable Care Act; (All provisions relating to health care.) S 1796 America's Healthy Future Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) S 1679 Affordable Health Choices Act; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 3200 America's Affordable Health Choices Act of 2009; (Provisions relating to medical device excise tax, medicare reimbursement rates for medical imaging, comparative effectiveness research.) HR 1549/S 619 the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; (Title II. General provisons in the bill.) HR 2749 Food Safety Enhancement Act of 2009 To amend the Federal Food, Drug, and cosmetic act to improve the safety of food in the global market, and for other purposes.) HR 3519/S 1709 Veterinary Services Investment Act (Support for legislation.) HR 2400 Strategies to Address Antimicrobial Resistance; (Section 3(c) relating to authorities over antimicrobial drug data collection.) S 510 Food Safety Modernization Act; (Provisions relating to strategy for comments.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H Res 317/S Res 174 Recognizing Kansas and Missouri as the animal health corridor in the US; (Support for the bill.) House and Senate Healthcare Reform bills; (Monitoring provisions relating to food animal antimicrobials and research.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 503/S. 311 To amend the Horse Protection Act to prohibit the shipping, transporting, moving, delivering, receiving, possessing, purchasing, selling, or donation of horses and other equines to be slaughtered for human consumption and other purposes; (Provisions relating to government authority over animal agriculture (15 U.S. C. 1822).)
* Chairman's Mark, Senate Finance, "The Children's Health Insurance Reauthorization Act of 2007"; (Sections relating to Medicaid rebates.) H.R. 4/S. 3 Medicare Prescription Drug Price Negotiation Act of 2007; (Provisions relating to extensions of pharmaceutical improvements, and sections to increase patent access and extend disease prevention provisions.) H.R. 4/S. 3 Medicare Prescription Drug Price Negotiation Act of 2007; (Provisions relating to extensions of pharmaceutical improvements, and sections to increase patent access and extend disease prevention provisions.)
H.R. 1684 To authorize appropriaions for the Department of Homeland Security for fiscal year 2008, and for other purposes; (Provisions relating to chemical plant security.) H.R. 2643/S. 1696 Making appropriations for the Department of the Interior, environment,and related agencies for the fiscal year ending September 30, 2008, and for other purposes; (Provisions relating to EPA funding, offshore drilling and pesticides.)
* H.R. 1908/S. 1145 A bill to amend title 35, United States Code, to provide for patent reform; (Provisions relating to patents.) H.R. 1908 The Patent Reform Act of 2007; (Sections pertaining to patent reform.) H.R. 1908/S. 1145 Patent Reform Act; (Provisions relating to modernize and harmonize the U.S. process for patent review and approvals.) H.R. 1908 The Patent Reform Act of 2007; (Sections pertaining to patent reform.) H.R. 1908/S. 1145 Patent Reform Act; (Provisions relating to modernize and harmonize the U.S. process for patent review and approvals.)
H.R. 1887/ S. 1179 Superfund Equity and Megasite Remediation Act of 2007; (All provisions pertaining to amendments of the Internal Revenue Code of 1986 to extend the financing for superfund for purposes of cleanup activities with respect to those Superfund sites for which removal and remedial action is estimated to cost more than $50,000, and for other purposes.)
H.R. 2125/S. 953 Rail Competition and Service Improvement Act of 2007; (All provisions relating to amendments that will ensure competition in the rail industry, enable rail customers to obtain reliable rail service, and provide those customers with a reasonable process for challenging rate and service disputes.)
* H.R. 1830 The Andean Trade Preferences Extension Package; (All provisions pertaining to the extension for eight months through February of 2008, duty free treatment of certain products from Bolivia, Columbia, Ecuador and Peru.) H.R. 2382, Thailand Democracy Act of 2007; (Provisions to harmonize and reduce the regulatory and cost burdens on particular business related imported product properties.) H.R. 1830 To Extend the Authorities of the Andean Trade Preference Act; (Provisions to harmonize and reduce the regulatory and cost burdens on particular business related imported product properites.) H.R.4653 To extend the temporary suspension of duty on ACM; (Provisions relating to the reduction of tariffs.) H.R.4654 To extend the temporary suspension of duty on Oxadiazon; (Provisions relating to the reduction of tariffs.) H.R.4635 To suspend temporarily the duty on Product mixtures containing Thiencarbazone-methyl (Methyl 4- H.R. 2382, Thailand Democracy Act of 2007; (Provisions to harmonize and reduce the regulatory and cost burdens on particular business related imported product properties.) H.R. 1830 To Extend the Authorities of the Andean Trade Preference Act; (Provisions to harmonize and reduce the regulatory and cost burdens on particular business related imported product properites.) H.R.4653 To extend the temporary suspension of duty on ACM; (Provisions relating to the reduction of tariffs.) H.R.4654 To extend the temporary suspension of duty on Oxadiazon; (Provisions relating to the reduction of tariffs.) H.R.4635 To suspend temporarily the duty on Product mixtures containing Thiencarbazone-methyl (Methyl 4-
H.R. 2638 Appropriations for Department of Homeland Security; (All provisions relating to preemption of federal law regarding chemical plant security.) S. 1644 Appropriations for Homeland Security; (All provisions relating to preemption of federal law regarding chemical plant secuity.)
H.R. 2784 The National Environmental and Energy Development Act; (All provisions relating to the supply of natural gas and oil and royalties from those supplies used to establish funds to help various projects along the Outer Continental Shelf.) H.R. 2337 The Energy Policy Reform and Revitilization Act of 2007; (All provisions pertaining to the promotion of energy policy reforms and public accountability, alternative energy and efficiency, and carbon capture and climate change mitigation, and for
H.R. 962/S. 549 The Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important anitbiotics used in the treatment of human and animal diseases; (Title II relating to definition of the use of critical anitmicrobial animal drugs in agriculture.)
H.R. 1148 Safe Food Act 2007; (Title II. Monitoring provisions relating to administration of Food Safety Programs.)
H.R. 2421/S. 1870 To amend the Federal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions relating to the definition of waters of the United States.)
* H.R. 2900 Food and Drug Administration Amendments of 2007; (Sections relating to user fee reauthorization.) S. 1082 The Food and Drug Administration Revialization Act of 2007; (Pertaining to FDA safety and user fees.) Chairman's Mark, Senate Finance, "The Children's Health Insurance Reauthorization Act of 2007; (Sections relating to Medicaid rebates.) H.R. 2900/H.R. 3580/S. 1082 To amend the FDA Act 2007 and to revise and extend the user fee programs for prescription drugs and medical devises; (Provisions relating to FDA animal drugs.) H.R. 3697/S. 2313 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug approval.) H.R. 2900/H.R. 3580/S. 1082 To amend the FDA Act 2007 and to revise and extend the user fee programs for prescription drugs and medical devises; (Provisions relating to FDA animal drugs.) H.R. 3697/S. 2313 Strategies to Address Antimicrobial Resistance; (Section 3 (c) relating to authorities over antimicrobial drug approval.)
H.R. 1650/S. 772 Railroad Anti-Trust Enforcement Act; (All provisions relating to amendments that will provide expanded coverage to the Federal Anti-Trust laws to eliminate exemptions from such laws.)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
* H.R. 4/S. 3, Medicare Prescription Drug Price Negotiation Act of 2007; (Provisions relating to extensions of pharmaceutical improvements, and sections to increase patent access and extend disease prevention provisions.) H.R. 4, Prescription Drug Negotiation Act of 2007; (Provisions concerning repealing non-interference in Medicare.) 17
* H.R. 2125/S. 953, the Rail Competition and Service Improvement Act of 2007; (All provisions relating to amendments that will ensure competition in the rail industry, enable rail customers to obtain reliable rail service, and provide those customers with a reasonable process for challenging rate and service disputes.) H.R. 1650/S. 772, The Railroad Anti-Trust Enforcement Act; (All provisions relating to amendments that will provide expanded coverage to the Federal Anti-Trust laws to eliminate exemptions from such laws that are contrary to the public interest with respect to railroads.) S. 1125, The Freight Rail Capacity Expansion Act of 2007; (All provisions pertaining to incentives to encourage investment in the expansion of freight rail infrastructure capacity through changes to the Internal Revenue Code of 1986 and to enhance modal tax equity.) H.R. 2125/H.R. 1650/S. 772/S. 953, A bill to amend the Federal antitrust laws to provide expanded coverage and to eliminate exemptions from such laws that are contrary to the public interest with respect to railroads; (Provisions relating to competitiveness of railroads.) 21
* H.R. 1830, The Andean Trade Preferences Extension Package; (All provisions pertaining to the extension for eight months through February of 2008, duty free treatment of certain products from Bolivia, Columbia, Ecuador and Peru.) H.R. 2382, Thailand Democracy Act of 2007; (Provisions to harmonize and reduce the regulatory and cost burdens on particular business related imported product properties.) H.R. 1830, To Extend the Authorities of the Andean Trade Preference Act; (Provisions to haromonize and reduce the regulatory and cost burdens on partiuclar business related imported product properties.) 23
* H.R. 1908/S. 1145, Patent Reform Act; (Provisions relating to modernize and harmonize the U.S. process for patent review and approvals.) S. 316, Preserve Access to Affordable Generics Act (Provisions relating to patent settlements.) S. 438, Fair Prescription Drug Competition Act of 2007; (Sections relating to authorized generics.) H.R. 1038, Access to Life-Saving Medicine Act (provisions relating to follow-on biologics.) H.R. 780, Counterfeit Drug Prevention Act of 2007 (Provisions relating to prevention of counterfeit drugs.) H.R. 1908/S. 1145, A bill to amend title 35, United States Code to provide for patent reform; (Provisions relating to patent reform.) H.R. 1908/S. 1145, A bill to amend title 35, United States Code, to provide for patent reform; (Provisions relating to patent reform.) 7 16 24
* H.R. 3161/S. 1859, to provide continuing appropriations for agriculture and related programs in FY 2008; (All provisions related to biotechnology and international trade programs at USDA.) H.R. 2643/S. 1696, Making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2008, and for other purposes; (Provisions relating to EPA Funding, offshore drilling and pesticides.) H.R. 1684, To authorize appropriations for the Department of Homeland Security for the fiscal year 2008, and for other purposes; (Provisions relating to chemical plant security.) H.R. 2643/S. 1696, Making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2008, and for other purposes; (Provisions relating to EPA funding, offshore drilling and pesticides.) 5 25
H.R. 2784, The National Environmental and Energy Development Act; (All provisions relating to the supply of natural gas and oil and royalties from those supplies used to establish funds to help various projects along the Outer Continental Shelf.) H.R. 2337, The Energy Policy Reform and Revitilization Act; (All provisions pertaining to the promotion of energy policy reforms and public accountability, alternative energy and efficiency, and carbon capture and climate change mitigation, and for other purposes.) S. 1227, The Clean Coal Act of 2007; (All provisions pertaining to amendments to the Clean Air Act that establish carbon dioxide new source performance standards for new coal-fired electric generated units.) S. 731 The National Carbon Dioxide Storage Capacity Assessment Act of 2007; (All provisions pertaining to amendments pertaining to methodologies to complete a national assessment of geological storage capacity for carbon dioxide, and for other purposes.) H.R. 1933/S. 962, The Department of Energy Carbon Capture and Storage Research, Development and Demonstration Act of 2007; (All provisions pertaining to the amendments of the Energy Policy Act of 2005 to reauthorize and improve the carbon capture and storage research, development, and demonstration program of the Department of Energy and for other purposes.) S. 506, High Performance Green Building Act of 2007; (All provisions relating to improve efficiency in the Federal Government through the use of high-performance green buildings, and for other purposes.) H.R. 2776, Renewable Energy and Energy Conservation Tax Act of 2007; (All provisions that would amend the Internal Revenue Code of 1986 to provide tax incentives for the production of renewable energy and energy conservation.) H.R. 6, The Energy Policy Overhaul Act (All provisions related to the combination of H.R. 2337; H.R. 2776; and other draft bills to be consolidated.)
H.R. 2638/S. 1644, Appropriations for Homeland Security; (All provisions relating to preemption of federal law regarding chemical plant security.)
* H.R. 1232/S. 746, To establish a competitive grant program to build capacity in veterinary medical education and expand the workforce of veterinarians engaged in public health practice and biomedical research; Section 2. Competitive Grants; (Provisions relating to entire bill.) S. 438, Fair Prescription Drug Competition Act of 2007; (Sections relating to authorized generics.) H.R. Access to Life -Saving Medicine Act; (Relating to follow-on biologics) H.R. 1165, Swift Approval, Full Evaluation Drug Act of the "SAFE Drug Act"; (Provisions relating to drug safety.) S. 21, A bill to provide for homeland security grant coordination and simplification, and for other purposes; (Sections relating to access to women's health therapies.) H.R. 970, Gang Prevention and Effective Deterrence Act of 2005; (Relating to bulk distribution of DXM.) H.R. 780, Counterfeit Drug Prevention Act of 2007; (Relating to prevention of counterfeit drugs.) H.R. 1282, Medigap Access Improvement Act; (Provisions relating to MediGap and hemophilia patients.) S. 1082, Prescription Drug User Fee Amendments of 2007; (Relating to FDA user fees reauthorization.) Full House Energy & Commerce Committee Markup of Committee prints on: PDUFA, MDUFMA, PREA, BPCA, Drug Safety; (Relating to reauthorization fo FDA user fees and safety.) H.R. 4, Prescription Drug Negotiation Act of 2007; (Provisions concerning repealing non-interference in Medicare.) S. 316, the "Preserve Access to Affordable Generics Act"; (Provisions relating to patent settlements.) 15
H.R. 503/S. 311, To amend the Horse Protection Act to prohibit the shipping, transporting, moving, delivering, receiving, possessing, purchasing, selling, or donation of horses and other equines to be slaughtered for human consumption and other purposes (Provisions relating to government authority over animal agriculture.) (15 U.S. C. 1822)
H.R. 1887/S.1179, Superfund Equity and Megasite Remediation Act of 2007; (All provisions pertaining to amendments of the Internal revenue Code of 1986 to extend the financing for Superfund for purposes of cleanup activities with respect to those Superfund sites for which removal and remedial action is estimated to cost more than $50,000,000, and for other purposes.)
H.R. 2421, To amend the Fereal Water Pollution Control Act to clarify the jurisdiction of the United States over waters of the United States; (Provisions relating to the definition of waters of the United States.)
H.R. 962/S. 549, A bill to amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antibiotics used in the treatment of human and animal diseases; title II; (Provisions relating to definition of the use of critical antimicrobial animal drugs in agriculture.) H.R. 1561/S. 1082, Food and Drug Administration Revitalization Act; (Monitoring amendments relating to FDA drug review process.) H.R. 1148, Food Safety Act 2007; (Monitoring provisions relating to FDA drug approval process.)
* HR 2419, To provide for the continuation of agricultural programs through fiscal year 2012, and for other purposes; (Provisions relating to farm commodity programs, conservation, pollinators and bio-fuels.) HR 2401, To provide for greater access and opportunities for socially disadvantaged farmers, to create incentives for research, conservation, and market viability, to provide a healthy and just work environment for agricultural workers, to provide Americans with healthier food choices, to address hunger and poverty in the United States, and for other purposes; Sections 401, 503, 505 -- 507, 607, 701 (Provisions relating to farm conservation programs.) H.R. 2913, To amend the administrative requirements for conservation programs administered by the Department of Agriculture to ensure a greater emphasis on increasing habitat for native and managed pollinators and establishing cropping systems, integrated pest management regimes, and other practices to protect native and managed pollinators, and for other purposes (Provisions relating to pollinators.) S. 1694/H.R. 1709, A bill to authorize resources for sustained research and analysis to address colony collapse disorder and the decline of North American pollinators (Provisions relating to pollinators.) S. 1496, A bill to amend the Food Security Act of 1985 to include pollinators in certain conservation programs (Provisions relating to pollinators.) H.R. 2419 To provide for the continuation of agricultural programs through fiscal year 2012, and for other purposes (Provisions relating to farm commodity programs, conservation, pollinators and bio-fuels.) H.R. 2401, To provide for greater access and opportunities for socially disadvantaged farmers, to create incentives for research, conservation, and market viability, to provide a healthy and just work environment for agricultural workers, to provide Americans with healthier food choices, to address hunger and poverty in the United States, and for other purposes; Sections 401, 503, 505 - 507, 607, 701; (Provisions relating to farm conservation programs.) H.R. 3161/S. 1859, To provide continuing appropriations for agriculture and related programs in FY 2008; (All provisions related to biotechnology and international trade programs at USDA.) H.R. 2913, To amend the administrative requirements for conservation programs administered by the Department of Agriculutre to ensure a greater emphasis on increasing habitat for native and managed pollinators and establishing cropping systems, integrated pest management regimes, and other practices to protect native and managed pollinators, and for other purposes; (Provisions relating to pollinators.) H.R. 1709/S. 1694, A bill to authorize resources for sustained research and analysis to address colony collapse disorder and the decline of North American pollinators; (Provisions relating to pollinators.) S. 1496, A bill to amend the Food Security Act of 1985 to include pollinators in certain conservation programs; (Provisions relating to pollinators.) H.R. 2419, Farm Bill Extension Act 2007 (Provisions related to title II Conservation Programs, Title IV Nutrition Programs) 1 2
Filing targets: HOUSE OF REPRESENTATIVES, SENATE